Prostatic Neoplasms, Castration-Resistant
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
9
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Prostatic Cancer, Castration-Resistant
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
12
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
malignant neoplasm of breast staging
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
49
|
1
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Ovarian Hyperstimulation Syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
64
|
24
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Female Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
71
|
15
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Malignant neoplasm of female breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
71
|
15
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Cervical intraepithelial neoplasia grade 1
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
75
|
1
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Cervical intraepithelial neoplasia grade 2
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
77
|
3
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Ovarian clear cell carcinoma
|
disease |
|
Neoplastic Process
|
103
|
|
0.060 |
None |
1.000 |
6 |
|
2012 |
2018 |
Retroviridae Infections
|
group |
Infections
|
Disease or Syndrome
|
112
|
1
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
HER2 gene amplification
|
disease |
|
Disease or Syndrome
|
170
|
14
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Sezary Syndrome
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
196
|
7
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Allergic Reaction
|
phenotype |
Immune System Diseases
|
Pathologic Function
|
197
|
1019
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Mycosis Fungoides
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
251
|
8
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Mean Corpuscular Volume (result)
|
phenotype |
|
Laboratory or Test Result
|
269
|
549
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
estrogen receptor-negative breast cancer
|
disease |
|
Neoplastic Process
|
356
|
40
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2014 |
Trichohepatoenteric Syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
424
|
28
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Lymphatic Metastasis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
463
|
10
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Barrett Esophagus
|
disease |
Digestive System Diseases; Neoplasms
|
Disease or Syndrome
|
478
|
60
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Oestrogen receptor positive breast cancer
|
disease |
|
Neoplastic Process
|
510
|
58
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2014 |
Red cell distribution width determination
|
phenotype |
|
Laboratory Procedure
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
RDW - Red blood cell distribution width result
|
phenotype |
|
Laboratory or Test Result
|
593
|
988
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Secondary malignant neoplasm of bone
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
647
|
18
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Finding of Mean Corpuscular Hemoglobin
|
phenotype |
|
Finding
|
653
|
1206
|
0.100 |
None |
1.000 |
2 |
1
|
2016 |
2019 |
Red Blood Cell Count measurement
|
phenotype |
|
Laboratory Procedure
|
717
|
1599
|
0.100 |
None |
1.000 |
2 |
1
|
2016 |
2019 |